John D. Ulm

Array ( [id] => 9319308 [patent_doc_number] => 20140051646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-20 [patent_title] => 'CELL PENETRATING PEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/966797 [patent_app_country] => US [patent_app_date] => 2013-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 15000 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13966797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9306523 [patent_doc_number] => 20140045197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'BIOMARKERS USED TO DETECT AND MONITOR NEUROLOGICAL AUTOIMMUNE DISEASES' [patent_app_type] => utility [patent_app_number] => 13/962571 [patent_app_country] => US [patent_app_date] => 2013-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 5201 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13962571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11407786 [patent_doc_number] => 09555071 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-31 [patent_title] => 'Methods and compositions for the treatment of axonal and neuronal degeneration' [patent_app_type] => utility [patent_app_number] => 13/917203 [patent_app_country] => US [patent_app_date] => 2013-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 2 [patent_no_of_words] => 7594 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13917203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10273924 [patent_doc_number] => 20150158921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-11 [patent_title] => 'AlphaO-SUPERFAMILY CONOTOXIN PEPTIDE, PHARMACEUTICAL COMPOSITION AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/407770 [patent_app_country] => US [patent_app_date] => 2013-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14931 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14407770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9205387 [patent_doc_number] => 20140004564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-02 [patent_title] => 'COMPOSITIONS AND METHODS FOR IMPROVED PROTEIN PRODUCTION' [patent_app_type] => utility [patent_app_number] => 13/913236 [patent_app_country] => US [patent_app_date] => 2013-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13369 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13913236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9269126 [patent_doc_number] => 20140024043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-23 [patent_title] => 'Mammalian Sweet and Amino Acid Heterodimeric Taste Receptors Comprising T1R3 and T1R1' [patent_app_type] => utility [patent_app_number] => 13/903820 [patent_app_country] => US [patent_app_date] => 2013-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 31021 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13903820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9280766 [patent_doc_number] => 20140030734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-30 [patent_title] => 'Biomarkers for Diseases of the Central Nervous System' [patent_app_type] => utility [patent_app_number] => 13/896382 [patent_app_country] => US [patent_app_date] => 2013-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8651 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13896382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9510943 [patent_doc_number] => 20140147435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-29 [patent_title] => 'NOGO-A Neutralizing Immunoglobulins for the Treatment of Neurological Diseases' [patent_app_type] => utility [patent_app_number] => 13/888764 [patent_app_country] => US [patent_app_date] => 2013-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15661 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13888764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9003087 [patent_doc_number] => 20130224212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'METHODS AND PRODUCTS RELATING TO GSK3SS REGULATION' [patent_app_type] => utility [patent_app_number] => 13/887679 [patent_app_country] => US [patent_app_date] => 2013-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 27901 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13887679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11256829 [patent_doc_number] => 09481722 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-01 [patent_title] => 'T1R taste receptors and genes encoding same' [patent_app_type] => utility [patent_app_number] => 13/886668 [patent_app_country] => US [patent_app_date] => 2013-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 28880 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13886668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9003696 [patent_doc_number] => 20130224821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'Light-Activated Chimeric Opsins and Methods of Using the Same' [patent_app_type] => utility [patent_app_number] => 13/875966 [patent_app_country] => US [patent_app_date] => 2013-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 23022 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13875966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10225747 [patent_doc_number] => 20150110741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-23 [patent_title] => 'COGNITIVE COMPOSITE PARAMETERS AND USES THEREOF FOR EVALUATING MULTIPLE SCLEROSIS' [patent_app_type] => utility [patent_app_number] => 14/395802 [patent_app_country] => US [patent_app_date] => 2013-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 31380 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 58 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14395802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9901009 [patent_doc_number] => 20150056209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-26 [patent_title] => 'PEPTIDE MIMOTOPES TO OXIDATION SPECIFIC EPITOPES' [patent_app_type] => utility [patent_app_number] => 14/388739 [patent_app_country] => US [patent_app_date] => 2013-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18221 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14388739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9120810 [patent_doc_number] => 20130287732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'Neuroprotection in Demyelinating Diseases' [patent_app_type] => utility [patent_app_number] => 13/850240 [patent_app_country] => US [patent_app_date] => 2013-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 14366 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13850240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9511952 [patent_doc_number] => 20140148445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-29 [patent_title] => 'Methods of Detecting Amyotrophic Lateral Sclerosis (ALS)' [patent_app_type] => utility [patent_app_number] => 13/833898 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 9095 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13833898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9421329 [patent_doc_number] => 20140105980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-17 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS AND RELATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/830521 [patent_app_country] => US [patent_app_date] => 2013-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 18497 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13830521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9149090 [patent_doc_number] => 20130303613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-14 [patent_title] => 'NRF2 Screening Assays and Related Methods and Compositions' [patent_app_type] => utility [patent_app_number] => 13/804283 [patent_app_country] => US [patent_app_date] => 2013-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10815 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13804283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10534891 [patent_doc_number] => 09260512 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-16 [patent_title] => 'Human IgM antibodies, and diagnostic and therapeutic uses thereof particularly in the central nervous system' [patent_app_type] => utility [patent_app_number] => 13/800117 [patent_app_country] => US [patent_app_date] => 2013-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 87 [patent_figures_cnt] => 87 [patent_no_of_words] => 64151 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13800117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9044595 [patent_doc_number] => 20130247233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-19 [patent_title] => 'G PROTEIN COUPLED RECEPTORS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/796312 [patent_app_country] => US [patent_app_date] => 2013-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 112557 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13796312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9864149 [patent_doc_number] => 20150044168 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-12 [patent_title] => 'Treatment of Multiple Sclerosis With Anti-CD19 Antibody' [patent_app_type] => utility [patent_app_number] => 14/384714 [patent_app_country] => US [patent_app_date] => 2013-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 21703 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14384714 [rel_patent_id] =>[rel_patent_doc_number] =>)